Search results
Results From The WOW.Com Content Network
What: Shares of biopharmaceutical company Jazz. Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're ...
Jazz Pharmaceuticals plc (a merger of Jazz Pharmaceuticals, Inc. and Azur Pharma plc) is a global biopharmaceutical company with a focus on oncology and neuroscience. It was founded in 2003 in California, United States. [2] One of the company's considerable products is the United States Food and Drug Administration (FDA) approved drug Xyrem ...
What: Shares of biopharmaceutical company Jazz. Skip to main content. Finance. 24/7 Help. For premium support please call: 800-290-4726 more ways to reach us. Login / Join. Mail ...
In March 2022, it was announced that Axsome Therapeutics would be acquiring Solriamfetol, under the brand name Sunosi, from Jazz Pharmaceuticals, for an upfront sum of $53 million. Jazz will receive a high single-digit royalty on Axsome's U.S. net sales of Sunosi in the current indication, and a mid-single-digit royalty in the future indications.
What: Shares of Jazz Pharmaceuticals (NAS: JAZZ) Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're ...
Mylan N.V. was a global generic and specialty pharmaceuticals company. In November 2020, Mylan merged with Upjohn, Pfizer 's off-patent medicine division, to form Viatris. [1] Previously, the company was domiciled in the Netherlands, with principal executive offices in Hatfield, Hertfordshire, UK [2] and a "Global Center" in Canonsburg ...
(Reuters) -Jazz Pharmaceuticals said on Thursday its experimental drug to treat a common movement disorder failed to reduce tremor severity in a mid-stage study, sending the company's shares down ...
Wyeth was a pharmaceutical company until it was purchased by Pfizer in 2009. The company was founded in Philadelphia, Pennsylvania, in 1860 as John Wyeth and Brother.Its headquarters moved to Collegeville, Pennsylvania, and Madison, New Jersey, before its headquarters were consolidated with Pfizer's in New York City after the 2009 merger.